Compare SGU & BIOA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SGU | BIOA |
|---|---|---|
| Founded | 1995 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Other Specialty Stores | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 431.4M | 481.0M |
| IPO Year | 1997 | 2024 |
| Metric | SGU | BIOA |
|---|---|---|
| Price | $12.97 | $6.36 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 9 |
| Target Price | N/A | ★ $35.63 |
| AVG Volume (30 Days) | 17.2K | ★ 814.9K |
| Earning Date | 08-05-2026 | 11-05-2026 |
| Dividend Yield | ★ 6.08% | N/A |
| EPS Growth | N/A | ★ 66.21 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $1,784,418,000.00 | $8,995,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $106.14 |
| P/E Ratio | $6.70 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $11.39 | $5.05 |
| 52 Week High | $13.53 | $25.96 |
| Indicator | SGU | BIOA |
|---|---|---|
| Relative Strength Index (RSI) | 59.03 | 26.14 |
| Support Level | $12.34 | N/A |
| Resistance Level | $13.20 | $8.53 |
| Average True Range (ATR) | 0.21 | 0.40 |
| MACD | 0.02 | 0.08 |
| Stochastic Oscillator | 80.85 | 14.57 |
Star Group LP is a home heating oil and propane distributor and services provider with one reportable operating segment that principally provides heating related services to residential and commercial customers. It serves residential and commercial customers whose primary use is to heat their homes and buildings in the Northeast and Mid-Atlantic U.S. regions. The company derives the majority of revenue from Petroleum products, which consist of home heating oil and propane as well as diesel fuel and gasoline.
Bioage Labs Inc is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases by targeting the biology of human aging. The company's technology platform and differentiated human datasets enable the identification of targets based on insights into molecular changes that drive aging. The Company operates and manages its business as one reportable and operating segment, which is the business of extending healthy human life by targeting molecular causes of aging.